Speaker illustration

Doctor Gabriel Brooks

London ()

Novel cardiotropic AAV variant C102 vectors show superior gene delivery & reduced immunogenicity in non-human primates, transduction of human cardiomyocytes, & correction of Fabry disease phenotype

Event: ESC CONGRESS 2019

Topic: Renal Failure and Cardiovascular Disease

Session: Risk Factors and Prevention, Cardiovascular Disease in Special Populations

Thumbnail

This platform is supported by

logo Novo Nordisk